日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay

利用仅血浆循环肿瘤DNA检测方法检测乳腺癌微小残留病灶并预测复发

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.104296
Janni, W; Rack, B; Friedl, T W P; Hartkopf, A D; Wiesmüller, L; Pfister, K; Mergel, F; Fink, A; Braun, T; Mehmeti, F; Uhl, N; De Gregorio, A; Huober, J; Fehm, T; Müller, V; Rich, T A; Dustin, D J; Zhang, S; Huesmann, S T
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

DETECT 研究计划中接受筛查的转移性乳腺癌患者循环肿瘤细胞 HER2 状态的预后意义

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100299
Müller, V; Banys-Paluchowski, M; Friedl, T W P; Fasching, P A; Schneeweiss, A; Hartkopf, A; Wallwiener, D; Rack, B; Meier-Stiegen, F; Huober, J; Rübner, M; Hoffmann, O; Müller, L; Janni, W; Wimberger, P; Jäger, B; Pantel, K; Riethdorf, S; Harbeck, N; Fehm, T
肿瘤
HER2
肿瘤免疫
TEC
乳腺癌
细胞生物学
肿瘤细胞
发表日期：2021
文献求助 收藏

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

早期乳腺癌患者接受辅助芳香化酶抑制剂治疗第一年期间，补充和替代医学与肌肉骨骼疼痛的关系

期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2019.12.017
Hack, C C; Häberle, L; Brucker, S Y; Janni, W; Volz, B; Loehberg, C R; Hartkopf, A D; Walter, C-B; Baake, G; Fridman, A; Malter, W; Wuerstlein, R; Harbeck, N; Hoffmann, O; Kuemmel, S; Martin, B; Thomssen, C; Graf, H; Wolf, C; Lux, M P; Bayer, C M; Rauh, C; Almstedt, K; Gass, P; Heindl, F; Brodkorb, T; Willer, L; Lindner, C; Kolberg, H-C; Krabisch, P; Weigel, M; Steinfeld-Birg, D; Kohls, A; Brucker, C; Schulz, V; Fischer, G; Pelzer, V; Rack, B; Beckmann, M W; Fehm, T; Rody, A; Maass, N; Hein, A; Fasching, P A; Nabieva, N
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study

前瞻性随机SUCCESS A研究中遗传性乳腺癌易感变异与预后的关系

期刊:Geburtshilfe Und Frauenheilkunde
影响因子:1.9
doi:10.1055/s-0042-113189
Hein, A; Rack, B; Li, L; Ekici, A B; Reis, A; Lux, M P; Cunningham, J M; Rübner, M; Fridley, B L; Schneeweiss, A; Tesch, H; Lichtenegger, W; Fehm, T; Heinrich, G; Rezai, M; Beckmann, M W; Janni, W; Weinshilboum, R M; Wang, L; Fasching, P A; Häberle, L
肿瘤
肿瘤免疫
乳腺癌
发表日期：2017
文献求助 收藏

Disseminated and circulating tumor cells in bone marrow and blood of breast cancer patients: properties, enrichment, and potential targets

乳腺癌患者骨髓和血液中播散性和循环性肿瘤细胞：特性、富集和潜在靶点

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-016-2118-3
Schindlbeck, C; Andergassen, U; Jueckstock, J; Rack, B; Janni, W; Jeschke, U
肿瘤
肿瘤免疫
乳腺癌
细胞生物学
肿瘤细胞
发表日期：2016
文献求助 收藏

Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial

一项评估 FEC-Doc 和 FEC-Doc 联合吉西他滨作为高危早期乳腺癌辅助治疗的 III 期研究的毒性评估：SUCCESS-A 试验

期刊:Geburtshilfe Und Frauenheilkunde
影响因子:1.9
doi:10.1055/s-0042-106209
Schröder, L; Rack, B; Sommer, H; Koch, J G; Weissenbacher, T; Janni, W; Schneeweiss, A; Rezai, M; Lorenz, R; Jäger, B; Schramm, A; Häberle, L; Fasching, P A; Friedl, T W P; Beckmann, M W; Scholz, C
肿瘤
毒理研究
肿瘤免疫
乳腺癌
发表日期：2016
文献求助 收藏

Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy

循环肿瘤细胞与客观疗效评估在预测接受多西他赛化疗的转移性去势抵抗性前列腺癌患者的生存期方面的作用

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-015-1936-z
Thalgott, M; Heck, M M; Eiber, M; Souvatzoglou, M; Hatzichristodoulou, G; Kehl, V; Krause, B J; Rack, B; Retz, M; Gschwend, J E; Andergassen, U; Nawroth, R
肿瘤
肿瘤免疫
细胞生物学
肿瘤细胞
前列腺癌
发表日期：2015
文献求助 收藏

Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients

激素疗法及其对乳腺癌患者预后的影响

期刊:Geburtshilfe Und Frauenheilkunde
影响因子:1.9
doi:10.1055/s-0035-1546149
Rauh, C; Schuetz, F; Rack, B; Stickeler, E; Klar, M; Orlowska-Volk, M; Windfuhr-Blum, M; Heil, J; Rom, J; Sohn, C; Andergassen, U; Jueckstock, J; Fehm, T; Loehberg, C R; Hein, A; Schulz-Wendtland, R; Hartmann, A; Beckmann, M W; Janni, W; Fasching, P A; Häberle, L
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2015
文献求助 收藏

Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer.

评价两种不同的分析方法在原发性乳腺癌患者外周血中循环肿瘤细胞检测中的应用

期刊:Biomed Research International
影响因子:2.3
doi:10.1155/2014/491459
Jaeger B A S, Jueckstock J, Andergassen U, Salmen J, Schochter F, Fink V, Alunni-Fabbroni M, Rezai M, Beck Th, Beckmann M W, Friese K, Friedl T W P, Janni W, Rack B
细胞生物学
肿瘤
乳腺癌
肿瘤免疫
发表日期：2014
文献求助 收藏

Participation in the SUCCESS-A Trial Improves Intensity and Quality of Care for Patients with Primary Breast Cancer

参与 SUCCESS-A 试验可提高原发性乳腺癌患者的治疗强度和质量

期刊:Geburtshilfe Und Frauenheilkunde
影响因子:1.9
doi:10.1055/s-0032-1328147
Andergassen, U; Kasprowicz, N S; Hepp, P; Schindlbeck, C; Harbeck, N; Kiechle, M; Sommer, H; Beckmann, M W; Friese, K; Janni, W; Rack, B; Scholz, C
肿瘤
肿瘤免疫
乳腺癌
发表日期：2013
文献求助 收藏